Indazole Compounds Inhibit Wnt Pathway Signaling
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for disorders associated with aberrant Wnt signaling, such as cancer and other diseases, lack effective inhibitors to modulate cellular events and correct genetic disorders caused by mutations in Wnt signaling components.
Innovation Solution
Development of indazole compounds and their salts or analogs that act as Wnt pathway inhibitors, specifically contacting cells with these compounds to antagonize Wnt activity and reverse aberrant growth states or correct genetic disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments are used for disorders associated with aberrant Wnt signaling, then existing therapeutic options are limited, but effective inhibition of Wnt pathway activity cannot be achieved
Solution Approach 1:
The patent employs parameter changes by systematically varying chemical structures of indazole compounds (Formula I) to optimize Wnt pathway inhibition. Different substituents (R1-R10 groups) are explored to achieve effective inhibition while maintaining desired pharmacological properties, directly addressing the need for reliable therapeutic effectiveness.
Solution Approach 2:
The invention creates composite therapeutic solutions by combining indazole core structures with various heteroaryl and heterocyclyl groups (R3, R5 substituents). This composite approach generates multiple analogs with potentially different efficacy profiles, expanding treatment options for Wnt-related disorders.
2Adaptability or versatility
If indazole compounds are developed to inhibit Wnt pathway activity, then therapeutic options are expanded, but the complexity of identifying effective compounds increases
Solution Approach 1:
The indazole compound structure is segmented into distinct functional regions: the core indazole ring, R3 heteroaryl/heterocyclyl substituent, and R5 aryl/heteroaryl substituent. This segmentation allows independent optimization of each region to achieve Wnt inhibition while managing overall molecular complexity.
Solution Approach 2:
The indazole core structure serves as a universal scaffold that can accommodate multiple different substituent patterns (R1-R10). This multi-functionality allows a single core structure to generate numerous analogs with potentially different efficacies and pharmacokinetic profiles, expanding treatment options without proportionally increasing structural complexity.
3Reliability
If Wnt pathway inhibition is achieved through indazole compounds, then cellular events are modulated, but the mechanism of action requires precise molecular interaction
Solution Approach 1:
The patent applies local quality by introducing specific substituents at defined positions (R1-R10) on the indazole core structure. Each substituent location provides localized chemical properties that facilitate precise molecular interactions with Wnt pathway components, ensuring reliable modulation of cellular events through controlled molecular recognition.
Data Source
AI summary
Indazole compounds for treating various diseases and pathologies are disclosed. More particularly, the present disclosure concerns the use of an indazole compound or analogs thereof, in the treatment of disorders characterized by the activation of Wnt pathway signaling (e.g., cancer, abnormal cellular proliferation, angiogenesis, fibrotic disorders, bone or cartilage diseases, and osteoarthritis), the modulation of cellular events mediated by Wnt pathway signaling, as well as genetic diseases and neurological conditions/disorders/diseases due to mutations or dysregulation of the Wnt pathway and/or of one or more of Wnt signaling components. Also provided are methods for treating Wnt-related disease states.